Cell Therapy Manufacturing & Gene Therapy Congress is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Tarik Senussi
Director, Process Development at Gyroscope Therapeutics Limited, UK


Tarik Senussi is the Head of Process Development at Gyroscope Therapeutics Ltd. Tarik joined Gyroscope in February 2017 and has been working on developing processes for rAAV manufacture from both suspension and adherent platforms. Prior to Joining Gyroscope Tarik was at GSK, as Lead Upstream Process Development Scientist, where he was responsible for establishing the upstream process development platform and team for the production of viral vectors. During this time, Tarik undertook support of StrimvellisTM the first ex-vivo cell and gene therapy to gain commercial approval and development of a suspension platform to progress pipeline assets. Prior to that Tarik worked at Medimmune Ltd as a scientist II and Lonza Biologics Ltd as a senior R&D scientist where he supported cell culture and fermentation sciences and new product development respectivelyTarik holds a BSc in Cell Biology and a PhD in Biochemical Engineering both from University College London.

Tarik Senussi's Network

Agenda Sessions

  • Planning for success: suspension platform development and tech transfer

    , 14:30